key: cord-0890957-7df29ldl authors: van den Borst, Bram; Peters, Jeannette B; Brink, Monique; Schoon, Yvonne; Bleeker-Rovers, Chantal P; Schers, Henk; van Hees, Hieronymus W H; van Helvoort, Hanneke; van den Boogaard, Mark; van der Hoeven, Hans; Reijers, Monique H; Prokop, Mathias; Vercoulen, Jan; van den Heuvel, Michel title: Comprehensive health assessment three months after recovery from acute COVID-19 date: 2020-11-21 journal: Clin Infect Dis DOI: 10.1093/cid/ciaa1750 sha: 87436d2db463696e7676358b84ec07de7417a3cd doc_id: 890957 cord_uid: 7df29ldl BACKGROUND: Long-term health sequelae of COVID-19 may be multiple but have thus far not been systematically studied. METHODS: All patients discharged after COVID-19 from the Radboud university medical centre, Nijmegen, The Netherlands, were consecutively invited to a multidisciplinary outpatient facility. Also, non-admitted patients with mild disease but with symptoms persisting >6 weeks could be referred by general practitioners. Patients underwent a standardized assessment including measurements of lung function, chest CT/X-ray, 6-minute walking test, body composition, and questionnaires on mental, cognitive, health status and quality of life (QoL). RESULTS: 124 patients (age 59±14 years, 60% male) were included; 27 with mild, 51 with moderate, 26 with severe and 20 with critical disease. Lung diffusion capacity was below lower limit of normal in 42% of discharged patients. Ninety-nine percent of discharged patients had reduced ground-glass opacification on repeat CT imaging, and normal chest X-rays were found in 93% of patients with mild diseases. Residual pulmonary parenchymal abnormalities were present in 91% of discharged patients, and correlated with reduced lung diffusion capacity. Twenty-two percent had low exercise capacity, 19% low fat-free mass index, and problems in mental and/or cognitive function were found in 36% of the patients. Health status was generally poor, particularly in the domains functional impairment (64%), fatigue (69%) and QoL (72%). CONCLUSIONS: This comprehensive health assessment revealed severe problems in several health domains in a substantial number of ex-COVID-19 patients. Longer follow-up studies are warranted to elucidate natural trajectories and to find predictors of complicated long-term trajectories of recovery. By 5 November 2020, the World Health Organization (WHO) reported >47 million confirmed Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) cases worldwide, and the number of daily new cases keeps on increasing [1] . Although the mortality rate is considerable, the vast majority of SARS-CoV-2 infected patients recovers from the acute phase. Long-term health consequences of this coronavirus disease (COVID- 19 ) are yet largely unknown but many patients are likely to experience long-lasting morbidity [2] . Indeed, based on observations from diseases that share COVID-19 characteristics such as Acute Respiratory Distress Syndrome [3] , SARS-CoV [4] , and Q-fever [5] , it is hypothesized that in the long-term a significant number of COVID-19 patients will suffer from lung function impairment, residual pulmonary parenchymal abnormalities, decreased physical capacity, loss of muscle mass, anxiety, depression, cognitive deficits, post-traumatic stress disorder, fatigue, and poor health status. We aimed to comprehensively assess these health domains in patients three months after recovery from acute COVID-19. This prospective observational study reports data of 124 patients who consecutively attended the COVID-19 aftercare facility at Radboud university medical center (Radboudumc), Nijmegen, The Netherlands. Within The Netherlands, the centre of the outbreak was close to the city of Nijmegen and the Radboudumc treated patients with moderate-to-critical COVID-19 also including patients who were transferred from other regions because of capacity problems. In the initial phase of the outbreak, SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) tests were not readily available for all patients with mild symptoms that did not require hospital admission; they were advised to stay at home in self-quarantine until respiratory symptoms resolved. Patients who had been discharged after inpatient treatment for COVID-19 were consecutively invited to the A c c e p t e d M a n u s c r i p t 5 aftercare facility. Also, general practitioner (GP) referrals of RT-PCR-confirmed or clinically suspect SARS-CoV-2 patients without hospitalization but with symptoms persisting >6 weeks were included. A standardized health assessment was performed that included questionnaires, physical measurements and multidisciplinary consultations followed by interdisciplinary case discussions. The team consisted of a pulmonologist, geriatrician, infectious diseases specialist, intensive care specialist, nurse practitioner, physiotherapist, psychologist, dietician, and social worker. Data was collected as part of the ongoing prospective observational POST-COVid-19 recovERY (POSTCOVERY) study, which was approved by the local medical ethics committee of Arnhem-Nijmegen, The [7] on admission, and comorbidities were collected from patients' medical records. Social status, education level and smoking status were collected via questionnaires. C-reactive protein, D-dimer, ferritin and leukocyte count at follow-up were collected. Resting pulse-oximetry was performed in sitting position at least five minutes and breathing room air. Spirometry, single-breath diffusion capacity and body plethysmography [8] [9] [10] were performed and outcomes were expressed according to reference values. Modified Medical Research Council (mMRC) dyspnea scale was assessed [11] . Discharged patients underwent low-dose chest CT imaging at follow-up. Scanning protocol and structured image interpretation by two independent chest radiologists are described in the online supplement. Referred mild disease patients underwent A c c e p t e d M a n u s c r i p t 6 conventional chest X-ray imaging and presence of residual COVID-19 abnormalities were collected from the radiological report. The degree of frailty was assessed with the Clinical Frailty Scale (CFS) [12] . Scores <5 can be considered as not frail, a score of 5 indicates somewhat frail, and scores >5 indicate frailty. A 6minute walking test (6MWT)[13] was performed and outcomes were expressed according to reference values. Desaturation upon the 6MWT was defined as a fall ≥4% of the resting saturation [14] . Anthropometry was assessed by measuring body height and weight and body mass index (BMI) was calculated as body weight/height 2 . Body composition was assessed by bio-electrical impedance analysis (BIA, Bodystat 500, EuroMedix, Leuven, Belgium) excluding patients with peripheral edema or pacemaker. Fat-free mass index (FFMI) was calculated as fat-free mass/height 2 , and age-, sex-and BMI-specific cut points were applied to determine the proportion of patients with FFMI10, HADS-depression>10, TICS<34, CFQ>43, PCL-5>33 and IES-R>33). A c c e p t e d M a n u s c r i p t 7 Health status was measured and valued with the Short Form Health survey (SF-36) [21] and the Nijmegen Clinical Screening Instrument (NCSI) [22, 23] . The SF-36 is consists of 8 subscales: physical functioning, social functioning, role functioning, role emotional, emotional well-being, energy/fatigue, pain and general health with higher scores indicating better health status. The NCSI is a battery of subscales from questionnaires that was empirically composed such that it provides a detailed measure of health status, while being short enough to be used in usual care. The NCSI measures 22 aspects of three health status domains: symptoms (pain, dyspnea [23] and fatigue[24]), functional impairments (behavioural impairment [25] and subjective impairment [26] ) and quality of life (general QoL [27, 28] , health-related QoL(HRQoL [23] ), and satisfaction with relations [23] ), with higher scores indicating worse health status. These 22 aspects are aggregated into ten dimensions for which cut points for normal, mild problems and severe problems were applied [22] . Received treatment by allied health care professionals (AHCP) between acute COVID-19 and day of outpatient visit was recorded. Advice following interdisciplinary case discussions was collected and grouped into one or more of the following categories: additional diagnostics, self-management advice, medication advice, specific advice to the GP, new referral to an AHCP, new referral to another medical specialist, and referral to specialized rehabilitation. Statistical analyses were performed using SPSS statistical software program, version 25.0. Betweengroup comparisons for continuous variables were tested by one-way analysis of variance or Kruskal-Wallis test. Categorical variables were tested with a Chi-square test. If a statistically significant difference was obtained, a post-hoc test was performed applying Bonferroni correction to account M a n u s c r i p t 8 for multiple comparisons. Within-group differences of continuous variables between baseline and follow-up were tested with paired t-tests. Missing data were handled by complete case analysis. A pvalue of <0.05 was considered significant. Between 23 April and 15 July 2020, 171 consecutively discharged COVID-19 patients were invited to the aftercare facility of whom 97 (57%) attended and were included in the analysis. Reasons for nonattendance are presented in Figure 1 . Compared to discharged patients included in the analysis, non-attendees had similar mean age, sex distribution, mean length of stay and distribution of COVID-19 severity grades (all p>0.05, data not shown). All twenty-seven referred mild disease patients were included. Collectively, this study describes the results of 124 patients. Table 1 provides demographics, acute COVID-19 characteristics, comorbidities, and the timing of outpatient follow-up. Critical disease patients were younger compared to moderate-tosevere disease patients and were predominantly male. Referred mild disease patients were younger than moderate-to-critical disease patients and were predominantly female. Increasing COVID-19 severity grade was paralleled by increases in CT severity scores, length of stay and prevalence of pulmonary embolism. Critical disease patients had a mean (SD) of 15 (8) ICU treatment days. Twenty-nine percent of moderate-to-critical disease patients had no comorbidities while this was 78% in referred mild disease patients. Critical disease patients had less comorbidity than moderate and severe disease patients. The assessment was performed at a mean (SD) of 13.0 (2.2) weeks after onset of SARS-CoV-2 symptoms and 9.1 (1.6) weeks after discharge. At follow-up, median CRP, Ddimer, ferritin and mean leukocyte count showed normal levels in all the study groups (Online Supplement Table 1 ). A c c e p t e d M a n u s c r i p t 9 Table 2 provides the data on dyspnea, lung function and CT imaging at follow-up. Referred mild disease patients reported higher mMRC than moderate-to-critical disease patients. Mean (SD) resting oxygen saturation was 96 (1) % and mean spirometric indices were normal across study groups. Mean diffusion capacity of the lungs for carbon monoxide (DLCO) was significantly lower in moderate-to-critical disease patients compared to referred mild disease patients who had normal mean DLCO. Critical disease patients had lowest mean total lung capacity (TLC) and residual volume (RV). Differences in lung function outcomes were unaffected when the 7 patients with chronic obstructive pulmonary disease/ emphysema were excluded (data not shown). Chest X-rays in referred mild disease patients were normal in 93% of cases; 2 patients (7%) had mild signs of bronchial disease. On follow-up CT imaging of discharged patients, 99% of patients had decreased ground-glass opacities (GGO); in 1% GGO was unchanged. Also, extent of residual pulmonary parenchymal abnormalities was significantly lower compared to admission (Figure 2A) . Nine percent of patients had no residual CT pulmonary abnormalities at all, while residual GGO, bronchi(ol)ectasis, lines or bands and radiological signs of fibrosis were present in 86%, 60%, 64%, and 26% of patients, respectively. No patient had signs of active organizing pneumonia and one (moderate disease) patient had minor residual crazy paving. Extent of residual abnormal pulmonary parenchymal involvement was significantly correlated with DLCO ( Figure 2B ). More specifically, presence and number of residual CT items were associated with lower DLCO (Figures 2C-D) . Presence of signs of residual fibrosis was also associated with older age (68 [12] versus 59 [12] in the referred mild disease group. Desaturators had lower DLCO than non-desaturators (65 (16) versus 85 (14) %predicted, p<0.001). Mean FFMI was normal while 19% of all patients had FFMI